Victrex chief commercial officer Martin Court to retire
Victrex plc
1,056.00p
16:55 20/12/24
High performance polymer solutions company Victrex said on Tuesday that chief commercial officer and executive director Dr Martin Court plans to retire after 10 years with the group.
Chemicals
7,037.77
17:14 20/12/24
FTSE 250
20,450.69
17:14 20/12/24
FTSE 350
4,463.29
17:14 20/12/24
FTSE All-Share
4,421.11
17:04 20/12/24
He will retire from the board after the September 2023 board meeting and will remain with the company until the end of December "to support a smooth transition".
Chief executive Jakob Sigurdsson said: "Martin has been an exceptional colleague and all of us at Victrex wish him well. He has been integral to Victrex's transition into a solutions-based company, as well as ensuring that our innovative culture translates across all of our growth programmes.
"He will retire at a time when a number of our mega-programmes are reaching an inflection point, with major OEM partnerships and line of sight to a material revenue opportunity over the coming years."
Court joined Victrex in 2013 as managing director, medical & emerging business. He joined the board in 2015 and was appointed as chief commercial officer in October 2019, to oversee the medical & industrial divisions, as well as a number of group functions, including marketing, sales, and research & development.